Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT)

CUSIP: 00650F109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
159,541,000
Total 13F shares
143,282,424
Share change
+444,628
Total reported value
$858,588,192
Put/Call ratio
139%
Price per share
$6.00
Number of holders
204
Value change
+$3,881,916
Number of buys
107
Number of sells
64

Security key

00650F109

Report period

Q4 2024

Institutions

204

Top holders

10

Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
19%
29,993,708
$153,567,785 30 Sep 2024
13F
Rubric Capital Management LP
13F
Company
9%
14,400,000
$73,728,000 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
7.5%
11,932,841
$61,096,147 30 Sep 2024
13F
ARK Investment Management LLC
13F
Company
7.3%
11,601,134
$59,397,807 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
6.7%
10,639,440
$54,473,933 30 Sep 2024
13F
Amova Asset Management Americas, Inc.
13D/G 13F
Nikko Asset Management Americas, Inc. · Company
4.6%
6,833,137
$53,981,782 $0 31 Dec 2024
Sumitomo Mitsui Trust Group, Inc.
13D/G 13F
Company
4.6%
6,833,137
$53,981,782 $0 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
4.3%
6,292,634
$49,711,809 $0 31 Dec 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
5.9%
9,400,573
$48,130,934 30 Sep 2024
13F
Aristotle Atlantic Partners, LLC
13F
Company
1.9%
3,001,201
$15,366,149 30 Sep 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
1.8%
2,881,364
$14,752,584 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
2,661,878
$13,631,763 30 Sep 2024
13F
STATE STREET CORP
13F
Company
1.6%
2,551,785
$13,065,139 30 Sep 2024
13F
Blue Water Life Science Advisors, LP
13F
Company
1.3%
2,145,145
$10,983,142 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
1,749,147
$8,955,632 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.89%
1,420,995
$7,274,704 30 Sep 2024
13F
Pier Capital, LLC
13F
Company
0.8%
1,275,885
$6,532,531 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.82%
1,301,783
$6,508,915 30 Sep 2024
13F
Soleus Capital Management, L.P.
13F
Company
0.7%
1,112,749
$5,697,275 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.66%
1,048,132
$5,366,436 30 Sep 2024
13F
Aberdeen Group plc
13F
Company
0.65%
1,029,447
$5,270,769 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.6%
963,532
$4,933,285 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.57%
916,743
$4,693,724 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.56%
887,833
$4,545,705 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.49%
779,131
$3,989,150 30 Sep 2024
13F
DDD Partners, LLC
13F
Company
0.48%
769,166
$3,938,130 30 Sep 2024
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.45%
718,656
$3,679,519 30 Sep 2024
13F
Cerity Partners LLC
13F
Company
0.44%
694,417
$3,555,416 30 Sep 2024
13F
Matrix Capital Management Company, LP
13F
Company
0.41%
650,000
$3,328,000 30 Sep 2024
13F
Clearline Capital LP
13F
Company
0.39%
614,593
$3,146,716 30 Sep 2024
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.32%
515,772
$2,640,753 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.32%
504,277
$2,581,898 30 Sep 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.31%
495,492
$2,536,919 30 Sep 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.27%
435,294
$2,228,705 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.23%
369,686
$1,892,791 30 Sep 2024
13F
Tycho Peterson
3/4/5
Chief Financial Officer
mixed-class rows
979,421
mixed-class rows
$1,828,542 04 Mar 2024
Nuveen Asset Management, LLC
13F
Company
0.22%
354,842
$1,816,791 30 Sep 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.19%
299,281
$1,532,319 30 Sep 2024
13F
PDT Partners, LLC
13F
Company
0.18%
280,382
$1,435,556 30 Sep 2024
13F
Millrace Asset Group, Inc.
13F
Company
0.17%
272,681
$1,396,000 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.16%
261,964
$1,341,255 30 Sep 2024
13F
Legato Capital Management LLC
13F
Company
0.15%
241,358
$1,235,753 30 Sep 2024
13F
FMR LLC
13F
Company
0.15%
233,566
$1,195,858 30 Sep 2024
13F
JENNISON ASSOCIATES LLC
13F
Company
0.15%
231,531
$1,185,439 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.14%
230,177
$1,178,506 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
209,426
$1,072,261 30 Sep 2024
13F
Robertson Stephens Wealth Management, LLC
13F
Company
0.12%
183,686
$940,472 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.11%
177,689
$908,000 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.11%
175,841
$900,292 30 Sep 2024
13F
Nitin Sood
3/4/5
Chief Commercial Officer, MRD
class O/S missing
214,808
$887,157 07 Aug 2023

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) as of Q4 2024

As of 31 Dec 2024, Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) was held by 204 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 143,282,424 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Rubric Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., MILLENNIUM MANAGEMENT LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and Soleus Capital Management, L.P.. This page lists 204 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
184
Q4 2024 holders
204
Holder diff
20
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .